Back

A community-driven digital health intervention for cardiovascular risk factor control: a cluster randomized controlled Trial

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Digital health interventions in cardiology: randomised trials and real-world implementation Patient Engagement and Personalised Health ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yingzhen Gu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Evaluation of an artificial intelligence-enhanced closed-loop digital system for risk factor control in coronary heart disease: a randomized clinical trial
Doctor Z. Ba (Beijing, CN)
Abstract
Presentation thumbnail
Health literacy and response to a mobile app–based exercise programme in heart failure: Insights from the EXERCISE-HF trial
Doctor K. Daigo (Tokyo, JP)
Abstract
Presentation thumbnail
Initial efficacy and feasibility of a novel patient support program for patients with cardiac implantable electronic devices and remote monitoring - the PARTICIPATE randomised controlled trial
Doctor B. Sheahen (Westmead, AU)
Abstract
Presentation thumbnail
Digital health divide by age: smartphone and wearable adoption patterns and perceived utility to improve health
Doctor C. Schach (Regensburg, DE)
Abstract
Presentation thumbnail
Evaluation of a human-in-the-loop pre-procedural clinical conversational AI calling system for cardiac catheterisation
Doctor G. Dangas (New York, US)
Abstract

Access the full session

Session thumbnail
Digital health interventions in cardiology: randomised trials and real-world implementation

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Reducing cardiovascular risk with an innovative solution mixing digital and human interventions
14 June 2025
thumbnail
Congress Presentation
A web-based self-management program to improve lifestyle and blood pressure control in patients with primary hypertension: a randomized controlled trial
29 August 2021
thumbnail
Congress Presentation
VICTORION-Mono China: efficacy and safety of inclisiran as monotherapy in Chinese adults with low or moderate ASCVD risk and elevated LDL-C
29 August 2025
thumbnail
Congress Presentation
Use of a smartphone application to increase adherence to medical treatment in patients with acute coronary syndrome: a randomized clinical trial.
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources